A Phase I/II Study of Cediranib (AZD2171) in Japanese Metastatic Colorectal Cancer Patients in Combination With FOLFOX

PHASE1/PHASE2CompletedINTERVENTIONAL

Enrollment

172

Participants

Timeline

Start Date

June 30, 2007

Primary Completion Date

October 31, 2009

Study Completion Date

August 31, 2012

Conditions

Metastatic Colorectal Cancer

Interventions

DRUG

AZD2171

oral tablet

DRUG

FOLFOX (5-fluorouracil, Leucovorin, Oxaliplatin)

intravenous infusion

DRUG

Placebo Cediranib

oral tablet

Trial Locations (2)

Research Site, Osaka

Research Site, Saitama